New NK1 receptor antagonists for the treatment of cancer and other illnesses related to Substance P (SP)
Wednesday, 27 January 2016
Researchers from the Faculty of Pharmacy at the University of Seville and the Institute of Chemical Research of the CSIC have developed a series of new compounds with high activity and selectivity for the treatment of distinct types of can-cer. The invention is directed towards the prevention and/or treatment not only of cancer but of
- Published in Health & life sciences
No Comments